204 related articles for article (PubMed ID: 19115673)
1. Mitoxantrone-related acute leukemia in two MS patients.
Pielen A; Goffette S; Van Pesch V; Gille M; Sindic CJ
Acta Neurol Belg; 2008 Sep; 108(3):99-102. PubMed ID: 19115673
[TBL] [Abstract][Full Text] [Related]
2. Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis.
Ramkumar B; Chadha MK; Barcos M; Sait SN; Heyman MR; Baer MR
Cancer Genet Cytogenet; 2008 Apr; 182(2):126-9. PubMed ID: 18406875
[TBL] [Abstract][Full Text] [Related]
3. Revision of the risk of secondary leukaemia after mitoxantrone in multiple sclerosis populations is required.
Pascual AM; Téllez N; Boscá I; Mallada J; Belenguer A; Abellán I; Sempere AP; Fernández P; Magraner MJ; Coret F; Sanz MA; Montalbán X; Casanova B
Mult Scler; 2009 Nov; 15(11):1303-10. PubMed ID: 19825889
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
Ellis R; Boggild M
Mult Scler; 2009 Apr; 15(4):505-8. PubMed ID: 19251838
[TBL] [Abstract][Full Text] [Related]
5. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
Sumrall A; Dreiling B
J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
[TBL] [Abstract][Full Text] [Related]
6. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukemic involvement of the optic nerves following mitoxantrone treatment for multiple sclerosis.
Ko MW; Tamhankar MA; Volpe NJ; Porter D; McGrath C; Galetta SL
J Neurol Sci; 2008 Oct; 273(1-2):144-7. PubMed ID: 18687447
[TBL] [Abstract][Full Text] [Related]
8. Four new cases of therapy-related acute promyelocytic leukemia after mitoxantrone.
Bosca I; Pascual AM; Casanova B; Coret F; Sanz MA
Neurology; 2008 Aug; 71(6):457-8. PubMed ID: 18678830
[No Abstract] [Full Text] [Related]
9. Risk of acute promyelocytic leukemia in multiple sclerosis: coding variants of DNA repair genes.
Hasan SK; Buttari F; Ottone T; Voso MT; Hohaus S; Marasco E; Mantovani V; Garagnani P; Sanz MA; Cicconi L; Bernardi G; Centonze D; Lo-Coco F
Neurology; 2011 Mar; 76(12):1059-65. PubMed ID: 21346221
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related acute leukemia in two patients with multiple sclerosis treated with Mitoxantrone.
Colovic N; Suvajdzic N; Kraguljac Kurtovic N; Djordjevic V; Dencic Fekete M; Drulovic J; Vidovic A; Tomin D
Biomed Pharmacother; 2012 Apr; 66(3):173-4. PubMed ID: 22440894
[TBL] [Abstract][Full Text] [Related]
11. Two new cases of acute promyelocytic leukemia following mitoxantrone treatment in patients with multiple sclerosis.
Ledda A; Caocci G; Spinicci G; Cocco E; Mamusa E; La Nasa G
Leukemia; 2006 Dec; 20(12):2217-8. PubMed ID: 17051242
[No Abstract] [Full Text] [Related]
12. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
[TBL] [Abstract][Full Text] [Related]
13. Genomic analysis of therapy-related acute promyelocytic leukemias arising after malignant and non-malignant disorders.
Ottone T; Hasan SK; Voso MT; Ledda A; Montefusco E; Fenu S; Pagoni M; Hubmann M; Lunghi M; Platzbecker U; Lo-Coco F
Am J Hematol; 2014 Mar; 89(3):346-7. PubMed ID: 24375429
[No Abstract] [Full Text] [Related]
14. Acute promyelocytic leukemia in a patient with multiple sclerosis following treatment with mitoxantrone.
Novoselac AV; Reddy S; Sanmugarajah J
Leukemia; 2004 Sep; 18(9):1561-2. PubMed ID: 15215874
[No Abstract] [Full Text] [Related]
15. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
Martinelli V; Cocco E; Capra R; Salemi G; Gallo P; Capobianco M; Pesci I; Ghezzi A; Pozzilli C; Lugaresi A; Bellantonio P; Amato MP; Grimaldi LM; Trojano M; Mancardi GL; Bergamaschi R; Gasperini C; Rodegher M; Straffi L; Ponzio M; Comi G;
Neurology; 2011 Nov; 77(21):1887-95. PubMed ID: 22076543
[TBL] [Abstract][Full Text] [Related]
16. Leukaemia due to mitoxantrone.
Prescrire Int; 2007 Aug; 16(90):153-6. PubMed ID: 17724842
[TBL] [Abstract][Full Text] [Related]
17. A case of acute promyelocytic leukaemia following mitoxantrone treatment of multiple sclerosis.
Cattaneo C; Almici C; Borlenghi E; Motta M; Rossi G
Leukemia; 2003 May; 17(5):985-6. PubMed ID: 12750718
[No Abstract] [Full Text] [Related]
18. Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.
Martinez V; Mir O; Dômont J; Bouscary D; Goldwasser F
Anticancer Drugs; 2007 Feb; 18(2):233-5. PubMed ID: 17159610
[TBL] [Abstract][Full Text] [Related]
19. Chronic myeloid leukemia associated with mitoxantrone treatment in a patient with MS.
Sadiq SA; Rammal M; Sara G
Mult Scler; 2008 Mar; 14(2):272-3. PubMed ID: 17986509
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
Singhal BS; Geeta S; Hundalani SG; Menon S
Neurol India; 2009; 57(4):418-23. PubMed ID: 19770542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
